Adnexal Lymphomas (adnexal + lymphoma)

Distribution by Scientific Domains

Kinds of Adnexal Lymphomas

  • ocular adnexal lymphoma


  • Selected Abstracts


    A possible new role for Helicobacter pylori in the development of ocular adnexal lymphoma,

    AMERICAN JOURNAL OF HEMATOLOGY, Issue 9 2010
    Sarah E. Coupland
    No abstract is available for this article. [source]


    Ocular adnexal lymphoma and Helicobacter pylori gastric infection,

    AMERICAN JOURNAL OF HEMATOLOGY, Issue 9 2010
    Didier Decaudin
    There is a causal association between Helicobacter pylori (Hp) gastric infection and the development of gastric MALT lymphoma. In contrast, the link between Hp gastric infection and the development of extragastric lymphoma has not been thoroughly investigated. We, therefore, studied the prevalence of gastric Hp infection at initial diagnosis of ophthalmologic and nonophthalmologic extragastric lymphoma patients. Three cohorts of patients were studied: a first one of 83 patients with OAL, a second one of 101 patients with extraophthalmologic extragastric lymphoma, and a third one of 156 control individuals (control) without malignant lymphoma. Gastric Hp infection was investigated by histopathological analysis and Hp -specific PCR assay on gastric biopsy tissue samples. We found gastric Hp infection in 37 OAL patients (45%), in 25 extraophthalmologic extragastric lymphoma cases (25%), and in 18 controls individuals (12%) (P < 0.0001 OAL/C and P < 0.01 OAL/extra-OAL cases). Gastritis was found in 51% and 9% of Hp -positive and Hp -negative lymphoma patients, respectively (P < 10,4). Gastric Hp infection only correlated with MALT/LPL lymphoma (P = 0.03). There is a significant association between gastric Hp infection and MALT/LPL OAL. This suggests a novel mechanism of indirect infection-associated lymphomagenesis whereby chronic local antigen stimulation would lead to the emergence of ectopic B-cell lymphoma. © 2010 Wiley-Liss, Inc. Am. J. Hematol. [source]


    Primary high-grade ocular adnexal lymphoma: Clinicopathological characteristics and prognostic factors of a single-centre series,

    AMERICAN JOURNAL OF HEMATOLOGY, Issue 5 2010
    Cristina Michaela Precupanu
    First page of article [source]


    4368: Hypermethylation of tumour suppressor genes in ocular adnexal lymphoma

    ACTA OPHTHALMOLOGICA, Issue 2010
    H MA
    Purpose Promoter hypermethylation occurs in various tumours, including ocular adnexal lymphomas (OAL), and is a mechanism by which tumour suppressor genes can be inactivated during tumourigenesis. This study aimed to investigate the levels of hypermethylation and specific genes that are hypermethylated in different subtypes of OAL using methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) and pryrosequencing. Methods DNA was extracted from formalin-fixed, paraffin-embedded tissues from 33 extra-marginal zone B-cell lymphomas (EMZL) and 37 non-EMZL. Using two MS-MLPA assays (MRC-Holland) the methylation status and copy number of 36 genes was detected. MS-MLPA results were validated using pyrosequencing. Results MLPA and pyrosequencing results were comparable with 75-100% concordancy. Ten common genes were hypermethylated in the EMZL and non-EMZL, diffuse large B-cell lymphomas (DLBCL) and mantle cell lymphomas (CDH13, DAPK1, ESR1, GATA5, IGSF4, PAX6, RAR,, THBS1, TIMP3, and WT1). In non-EMZLs, a greater number of genes showed hypermethylation when diagnosed in the orbit and patients had a poorer prognosis. Deletion of the 9p21 region was seen in 7/13 DLBCLs including the p14ARF, p15 and p16 genes. Conclusion Hypermethylation is a feature of OALs suggesting a role for epigenetic deregulation in OAL development. In non-EMZLs greater epigenetic deregulation may be indicative of poorer patient prognosis. We hypothesise that EMZL, DLBCL and mantle cell lymphomas share a similar epigenetic aetiology and that genes in the 9p21 region may be important to DLBCL development. Correlation of hypermethylation and copy number data with clinical presentation and follow-up could reveal biomarkers of diagnostic and prognostic value in OALs. [source]


    Genetic and epigenetic changes linked to Chlamydophila psittaci -associated ocular adnexal lymphomas

    HEMATOLOGICAL ONCOLOGY, Issue 1 2010
    Riccardo Dolcetti
    No abstract is available for this article. [source]


    4368: Hypermethylation of tumour suppressor genes in ocular adnexal lymphoma

    ACTA OPHTHALMOLOGICA, Issue 2010
    H MA
    Purpose Promoter hypermethylation occurs in various tumours, including ocular adnexal lymphomas (OAL), and is a mechanism by which tumour suppressor genes can be inactivated during tumourigenesis. This study aimed to investigate the levels of hypermethylation and specific genes that are hypermethylated in different subtypes of OAL using methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) and pryrosequencing. Methods DNA was extracted from formalin-fixed, paraffin-embedded tissues from 33 extra-marginal zone B-cell lymphomas (EMZL) and 37 non-EMZL. Using two MS-MLPA assays (MRC-Holland) the methylation status and copy number of 36 genes was detected. MS-MLPA results were validated using pyrosequencing. Results MLPA and pyrosequencing results were comparable with 75-100% concordancy. Ten common genes were hypermethylated in the EMZL and non-EMZL, diffuse large B-cell lymphomas (DLBCL) and mantle cell lymphomas (CDH13, DAPK1, ESR1, GATA5, IGSF4, PAX6, RAR,, THBS1, TIMP3, and WT1). In non-EMZLs, a greater number of genes showed hypermethylation when diagnosed in the orbit and patients had a poorer prognosis. Deletion of the 9p21 region was seen in 7/13 DLBCLs including the p14ARF, p15 and p16 genes. Conclusion Hypermethylation is a feature of OALs suggesting a role for epigenetic deregulation in OAL development. In non-EMZLs greater epigenetic deregulation may be indicative of poorer patient prognosis. We hypothesise that EMZL, DLBCL and mantle cell lymphomas share a similar epigenetic aetiology and that genes in the 9p21 region may be important to DLBCL development. Correlation of hypermethylation and copy number data with clinical presentation and follow-up could reveal biomarkers of diagnostic and prognostic value in OALs. [source]


    Ophthalmic lymphoma: epidemiology and pathogenesis

    ACTA OPHTHALMOLOGICA, Issue thesis1 2009
    Lene Dissing Sjö
    Abstract With a lifetime risk of 1% and 700 new cases per year, Non-Hodgkin lymphoma (NHL) is the seventh most frequent type of cancer in Denmark. The incidence of NHL has increased considerably in Western countries over the last decades; consequently, NHL is an increasing clinical problem. Ophthalmic lymphoma, (lymphoma localized in the ocular region, i.e. eyelid, conjunctiva, lacrimal sac, lacrimal gland, orbit, or intraocularly) is relatively uncommon, accounting for 5%,10% of all extranodal lymphomas. It is, however, the most common orbital malignancy. The purpose of this thesis was to review specimens from all Danish patients with a diagnosis of ophthalmic lymphoma during the period 1980,2005, in order to determine the distribution of lymphoma subtypes, and the incidence- and time trends in incidence for ophthalmic lymphoma. Furthermore, an extended analysis of the most frequent subtype, extranodal marginal zone lymphoma (MALT lymphoma), was done to analyse clinical factors and cytogenetic changes with influence on prognosis. A total of 228 Danish patients with a biopsy-reviewed verified diagnosis of ocular adnexal-, orbital-, or intraocular lymphoma were identified. We found that more than 50% of orbital- and ocular adnexal lymphomas were of the MALT lymphoma subtype, whereas diffuse large B-cell lymphoma (DLBCL) predominated intraocularly (Sjo et al. 2008a). Furthermore, lymphoma arising in the lacrimal sac was surprisingly predominantly DLBCL (Sjo et al. 2006). Incidence rates were highly dependent on patient age. There was an increase in incidence rates for the whole population from 1980 to 2005, corresponding to an annual average increase of 3.4% (Sjo et al. 2008a). MALT lymphoma arising in the ocular region was found in 116 patients (Sjo et al. 2008b). One third of patients had a relapse or progression of disease after initial therapy and relapses were frequently found at extra-ocular sites. Overall survival, however, was not significantly poorer for patients with relapse. Furthermore, we found that the frequency of translocations involving the MALT1- and IGH-gene loci is low in ocular region MALT lymphoma (2 of 42, 5%), but may predict increased risk of relapse (Sjo et al. 2008b). In conclusion the incidence of ophthalmic lymphoma is increasing at a high rate in Denmark. Ophthalmic lymphoma consists primarily of MALT lymphoma. The molecular pathogenesis of MALT lymphoma arising in the ocular region rarely involves translocations in the MALT1- and IGH-gene loci. [source]


    Current and possible future treatment of ocular adnexal lymphomas

    ACTA OPHTHALMOLOGICA, Issue 2008
    A PETTITT
    Purpose To review the current and possible future therapies of ocular adnexal lymphomas. Methods Ocular adnexal lymphomas represent approx. 8% of all extranodal lymphomas. The majority of these can be classified as extranodal marginal zone (MALT) lymphomas, and are usually staged as Stage IE disease. Results Recommended therapy in Stage IE tumours is low-dose radiotherapy, while disseminated disease (>Stage IIE) is treated with chemotherapy. Although often responding to initial therapy, the MALT lymphomas tend to recur in distant extranodal sites. Few biomarkers are available to aid prediction of either recurrence or systemic dissemination, which occurs in up to 25% of patients. The ocular morbidity associated with current therapies is not insignificant, and, therefore, more effective treatment is being sought. Conclusion The newer treatment options, including rituximab and doxycyclin, will be discussed [source]